Literature DB >> 10602545

A survey of congenital Chagas' disease, carried out at three health institutions in São Paulo City, Brazil.

I V Nisida1, V Amato Neto, L M Braz, M I Duarte, E S Umezawa.   

Abstract

The congenital transmission of Chagas' disease was evaluated in 57 pregnant women with Chagas' disease and their 58 offspring. The patients were selected from three Health Institutions in São Paulo City. The maternal clinical forms of Chagas' disease were: indeterminate (47.4%), cardiac (43.8%) and digestive (8.8%); 55 were born in endemic areas and two in São Paulo City. The transmission of Chagas' disease at fetal level was confirmed in three (5.17%) of the 58 cases studied and one probably case of congenital Chagas' disease. Two infected infants were born to chagasic women with HIV infection and were diagnosed by parasitological assays (microhematocrit, quantitative buffy coat-QBC or artificial xenodiagnosis). In both cases the placenta revealed T. cruzi and HIV p24 antigens detected by immunohistochemistry. In one case, a 14-week old abortus, the diagnosis of congenital T. cruzi infection was confirmed by immunohistochemistry. The other probable infection, a 30-week old stillborn, the parasites were found in the placenta and umbilical cord. The Western blot method using trypomastigote excreted/secreted antigens of T. cruzi (TESA) was positive for IgG antibodies in 54/55 newborns and for IgM in 1/55 newborns. One of the two newborns with circulating parasites had no detectable IgG or IgM antibodies. The assessment of IgG antibodies in the sera of pregnant women and their newborns was performed by ELISA using two different T. cruzi antigens: an alkaline extract of epimastigotes (EAE) and trypomastigote excreted/secreted antigens (TESA). The analysis showed a linear correlation between maternal and newborn IgG antibody titers at birth.

Entities:  

Mesh:

Year:  1999        PMID: 10602545     DOI: 10.1590/s0036-46651999000500007

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  5 in total

Review 1.  Emerging and reemerging forms of Trypanosoma cruzi transmission.

Authors:  Maria Aparecida Shikanai Yasuda
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-05-16       Impact factor: 2.747

2.  Risk factors associated with triatomines and its infection with Trypanosoma cruzi in rural communities from the southern region of the State of Mexico, Mexico.

Authors:  Imelda Medina-Torres; Juan C Vázquez-Chagoyán; Roger I Rodríguez-Vivas; Roberto Montes de Oca-Jiménez
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

3.  Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta.

Authors:  Guillermina Laura Dolcini; María Elisa Solana; Guadalupe Andreani; Ana María Celentano; Laura María Parodi; Ana María Donato; Natalia Elissondo; Stella Maris González Cappa; Luis David Giavedoni; Liliana Martínez Peralta
Journal:  Retrovirology       Date:  2008-07-01       Impact factor: 4.602

4.  Congenital transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: study protocol.

Authors:  Pierre Buekens; Maria-Luisa Cafferata; Jackeline Alger; Fernando Althabe; José M Belizán; Yves Carlier; Alvaro Ciganda; Eric Dumonteil; Rubi Gamboa-Leon; Elizabeth Howard; Maria Luisa Matute; Sergio Sosa-Estani; Carine Truyens; Dawn Wesson; Concepcion Zuniga
Journal:  Reprod Health       Date:  2013-10-11       Impact factor: 3.223

5.  Human chagas disease and migration in the context of globalization: some particular aspects.

Authors:  João Carlos Pinto Dias
Journal:  J Trop Med       Date:  2013-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.